In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, Bristol Myers Squibb, and AstraZeneca. As North ...

Leading pharmaceutical companies such as Mylan Pharmaceuticals Inc., AstraZeneca PLC, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., and many others are actively involved in developing innovative ...

Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...

Shares of GSK PLC GSK slipped 6.07% to £13.32 Monday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 4.38% to 7,702.08. GSK PLC ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in its marketing and prescription ...

Dublin, April 14, 2025 (GLOBE NEWSWIRE) -- The "Protein Engineering Market Report 2025" has been added to ResearchAndMarkets.com's offering. The protein engineering market size has grown rapidly ...

GLAXOSMITHKLINE Plc is right to snub Unilever Plc’s £50bil (US$68bil or RM284bil) proposal to buy the UK drugmaker’s consumer healthcare arm. Unilever’s offer may be in the ballpark ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated ...